Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing innovative treatments for life-threatening immune and thrombotic conditions, today highlighted recent scientific ...
Late-breaking presentation of results from the Phase 3 CORALreef AddOn trial evaluating enlicitide decanoate, Merck’s investigational oral PCSK9 inhibitor, which may help address the cardiovascular ...
Merck to present new data from cardio-pulmonary pipeline at the ACC.26 in New Orleans, from March 28-30: Rahway, New Jersey Tuesday, March 17, 2026, 17:00 Hrs [IST] Merck, known a ...
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with ...
New data show that blarcamesine completely rescued impaired motor functionBiomarker of nerve fiber density of dopaminergic nerve cells indicating ...
Advanced proteomics and AI reveal blood protein changes, offering insights into early Alzheimer's detection and differentiation from mild cognitive impairment.
Given the success of the <a href=" edition of Altered Metabolic Traits in Gastrointestinal Tract Cancers, we are pleased to announce the Volume II.<br/><br/>The field of gastrointestinal (GI) tract ...
Investigators sought to determine whether adding gedatolisib to fulvestrant, with or without palbociclib, improved clinical outcomes in patients with HR-positive/HER2-negative/PIK3CA wild-type ...
The Odisha Staff Selection Commission (OSSC) has released 124 vacancies for Amin, Junior Fisheries Technical Assistant, and Junior Forensic Attendant posts through OSSC CHSL recruitment. Candidates ...
In 2024, the International Diabetes Federation published a position statement supporting the 1 h 75 g oral glucose tolerance test (OGTT) as an alternative to the conventional 2 h testing protocol and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results